Sergio Abrignani

19.1k citations
175 papers · 12.7k indexed · 3 hit papers · h-index 60

Impact in

  • Hepatology top 0.05%
    • Hepatitis C virus research
  • Immunology top 0.2%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses

Papers in

    • Hepatitis C virus research 58
    • Immune Cell Function and Interaction 53
    • T-cell and B-cell Immunology 51
    • Immunotherapy and Immune Responses 23

Sergio Abrignani

172 papers receiving 12.4k citations

Hit Papers

High-dose vitamin C enhances cancer immunotherapy 2020 · 199 citations
199199620262006201650010001.5k

Peers

Sergio Abrignani
Comparison fields: 5 of 159
  • Hepatology 5.3k
  • Immunology 4.7k
  • Virology 1.0k
  • Epidemiology 4.6k
  • Radiology, Nuclear Medicine and Imaging 1.7k
Replace Thomas F. Baumert with:
Thomas F. Baumert France
Dorothy H. Crawford Australia
Georg M. Lauer United States
Jane A. McKeating United Kingdom
Barbara Rehermann United States
Robert Thimme Germany
Massimo Levrero Italy
Nobuyuki Kato Japan
Pierre Tiollais France
Michinori Kohara Japan
Sergio Abrignani relative to Thomas F. Baumert France Thomas F. Baumert's profile →
Citations per field
00.5×2.6×
Thomas F. Baumert · 1×
Citations per year

Countries citing papers authored by Sergio Abrignani

Since Specialization
Citations

This map shows the geographic impact of Sergio Abrignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Abrignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Abrignani more than expected).

Fields of papers citing papers by Sergio Abrignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Abrignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Abrignani. The network helps show where Sergio Abrignani may publish in the future.

Co-authors

The 25 scholars most cited alongside Sergio Abrignani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sergio Abrignani Line = papers co-authored together Sergio Abrignani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202418
2 20242
3 20240
4 20241
5 20227
6 202114
7 202128
8 202113
9 202113
10 202051
11
High-dose vitamin C enhances cancer immunotherapy
Hit paper breakdown →
2020199
12 201727
13 201754
14 2015268
15 201525
16 201368
17 201051
18 2007189
19 200635
20 200413

About Sergio Abrignani

Sergio Abrignani is a scholar working on Hepatology, Immunology, Virology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 175 papers that have together received 12.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (58 papers), Immune Cell Function and Interaction (53 papers), T-cell and B-cell Immunology (51 papers), Hepatitis B Virus Studies (30 papers), Monoclonal and Polyclonal Antibodies Research (27 papers), Immunotherapy and Immune Responses (23 papers), Liver Disease Diagnosis and Treatment (14 papers) and Systemic Lupus Erythematosus Research (12 papers). The work is most often cited by research in Hepatology (5.3k citations), Immunology (4.7k citations), Virology (1.0k citations), Epidemiology (4.6k citations) and Radiology, Nuclear Medicine and Imaging (1.7k citations). Sergio Abrignani has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Michael Houghton, Piero Pileri, Domenico Rosa, Susanna Campagnoli, Massimiliano Pagani, Yasushi Uematsu, Guido Grandi, Amy J. Weiner, Sandra Nuti and Derya Unutmaz. Their work appears in journals such as European Journal of Immunology, Frontiers in Immunology, The Journal of Immunology, Proceedings of the National Academy of Sciences and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026